| Item | n (%) | mean ± SD | |
| Age | 64.8 ± 5.9 | ||
| sex | man | 10 (66.6) | |
| woman | 4 (33.4) | ||
| Type of cancer | Sigmoid colon | 7 (50.0) | |
| pancreas | 1 (8.3) | ||
| lung | 4 (25.0) | ||
| breast | 2 (16.7) | ||
| Regimen | ZALTRAP + FOLFIRI | 3 (16.7) | |
| FOLFIRI + Pmab | 2 (16.7) | ||
| GEM/nab-PTX | 3 (16.7) | ||
| FOLFOXIRI + Bmab | 1 (8.2) | ||
| PEM + Pembrolizumab | 3 (25.0) | ||
| EC | 2 (16.7) | ||
| Employed/Working | 4 (25.0) | ||
| Family structure | Single | 3 (25.0) | |
| Couple and children | 11 (75.0) | ||
| Months of chemotherapy experience | 10.3 ± 3.2 | ||